Stay updated with breaking news from Steph Mountifield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brexafemme complements GSK’s industry-leading infectious disease portfolio with an FDA approved treatment for vulvovaginal candidiasisSCYNEXIS will receive an upfront payment of $90 million with... | March 30, 2023
Investegate announcements from GSK PLC, ViiV Healthcare announces Cabenuva positive data
12-month findings from the SOLAR study showed that the every-two-month regimen of CAB+RPV LA demonstrated non-inferior efficacy compared to continuation of daily oral BIC/FTC/TAF 90% of participants
/PRNewswire/ -- GSK plc (LSE/NYSE: GSK) today reports that the US Food and Drug Administration (FDA) granted full approval for Jemperli (dostarlimab-gxly) for...
Investegate announcements from GSK PLC, Jemperli full FDA approval following GARNET trial